
Cleveland Clinic Cancer Advances
A Cleveland Clinic podcast for medical professionals exploring the latest innovative research and clinical advances in the field of oncology.
Episodes
225 episodes
Rethinking Pediatric Hodgkin Lymphoma Care
The Cancer Advances Podcast is joined by the Chair of the Division of Pediatric Hematology Oncology and Director of the Bone Marrow Transplant Program, Rabi Hanna, MD, along with Ilia Butoriarov, MD, a physician at the Division of Pediatric Hem...
•
24:40

Molecular Insights into Early-Onset Biliary Tract Cancer
Alok Khorana, MD, Director of the Gastrointestinal Malignancies Program at Cleveland Clinic Cancer Institute, joins the Cancer Advances Podcast to break down the latest research on early-onset biliary tract cancer, diving into the genetic and m...
•
18:35

Advances in Treating Mandibular Osteoradionecrosis
Michael Fritz, MD, Director of the Section of Facial Plastic and Reconstructive Surgery at Cleveland Clinic, joins the Cancer Advances Podcast to talk about the approaches to the classification and management of mandibular osteoradionecrosis (O...
•
20:59

Advancing Multiple Myeloma Treatment
The Cancer Advances podcast is joined by hematologists Sandra Mazzoni, DO and Shahzad Raza, MD to discuss the latest advancements in multiple myeloma treatment. Listen as they explore the evolving role of CAR-T cell therapy, bispecific antibodi...
•
20:57

The MiDe Study’s Approach to Predict, Prevent and Detect Ovarian Cancer
Kevin Elias, MD, the Lilli and Seth Harris Endowed Chair for Ovarian Cancer at Cleveland Clinic, joins the Cancer Advances podcast to discuss the challenges of trying to detect ovarian cancer early and the need for better predictive tools. List...
•
21:26

Insights into Advanced Surgical Techniques for Neuroblastoma
Gloria Gonzalez, MD, Pediatric Surgeon and Director of Pediatric Surgical Oncology, joins the Cancer Advances podcast to provide her insights on advanced surgical techniques for neuroblastoma. Listen as Dr. Gonzalez explains the complexities of...
•
20:55

Integrative Oncology Program
The Cancer Advances podcast is joined by the Chair of the Palliative and Supportive Care Department, Laura Shoemaker, DO, and Integrative Medicine Specialist, Naoki Umeda, MD, to talk about Cleveland Clinic’s Integrative Oncology Program. Liste...
•
21:24
.png)
Bispecific Antibodies and Immunotherapy for Aggressive Lymphomas
Paolo Caimi, MD, Associate BMT Director for Cell Therapy at Cleveland Clinic Cancer Institute, joins the Cancer Advances podcast to discuss the latest advancements in immunotherapy for aggressive lymphomas. Listen as Dr. Caimi talks about the p...
•
19:22

The Potential of CAR T-Cell Therapy for Chronic Lymphocytic Leukemia (CLL)
Vice Chair of the Center for Immunotherapy & Precision Immuno-Oncology, J. Joseph Melenhorst, PhD, joins the Cancer Advances Podcast to discuss the potential of CAR T-cell therapy for chronic lymphocytic leukemia (CLL). Listen as Dr. Melenh...
•
17:32

Exploring Intermittent Therapy for Metastatic Renal Cell Carcinoma
Moshe Ornstein, MD, MA, a Genitourinary Medical Oncologist joins the Cancer Advances podcast to talk about intermittent therapy for metastatic renal cell carcinoma (mRCC). Listen as Dr. Ornstein explores the evolution of treatment options, from...
•
20:17

Real-World Insights on Bispecific Antibodies for Relapsed/Refractory Large B-Cell Lymphomas
Medical Oncologist in the Lymphoid Malignancies Division, Taylor Brooks, MD, joins the Cancer Advances podcast to discuss real-world data on bispecific antibodies for relapsed or refractory large B-cell lymphomas that was presented at the 2024 ...
•
20:43

Advancing Pelvic Sarcoma Reconstruction with 3D Printing
Lukas Nystrom, MD, Orthopaedic Oncology Surgeon and a Co-Director of the Sarcoma Program at Cleveland Clinic joins the Cancer Advances Podcast to talk about the advancements in custom 3D-printed implants for pelvic sarcoma reconstruction. Liste...
•
18:59

Resensitizing Triple-Negative Breast Cancer: Targeting the YES1 Protein
Ruth Keri, PhD, Associate Director for Basic Research at Case Comprehensive Cancer Center and Professor of Cancer Biology at Cleveland Clinic, returns to the Cancer Advances Podcast to share the latest advancements in targeting YES1 protein to ...
•
17:56

Exploring Stereotactic Body Radiation Therapy (SBRT) for Recurrent Osteosarcoma
The Cancer Advances podcast is joined by Director of Pediatric Radiation Oncology, Erin Murphy, MD, and resident physician, Jenna Kocsis, MD, to share their latest findings on the use of stereotactic body radiation therapy (SBRT) to treat recur...
•
16:10

Breaking the Silence: Addressing Sexual Health in Cancer Patients
Theresa Callard-Moore, PhD, LSW, a psychotherapist and certified sex therapist at Cleveland Clinic, joins the Cancer Advances podcast to shed light on the often-overlooked topic of sexual health in cancer patients. In this episode, Dr. Callard-...
•
19:42

Unlocking the Impact of ESR1 Mutations and PI3K Pathway on Elacestrant in Advanced Breast Cancer
Ali Azka, MD, medical oncologist specializing in breast cancer joins the Cancer Advances podcast to talk about her new research on ESR1 mutations and the PI3-kinase pathway's impact on the effectiveness of elacestrant in treating advanced hormo...
•
23:48

Integrated Program for Young People with Cancer
Chair of the Department of Colorectal Surgery, Director of the Weiss Center for Hereditary GI Neoplasia and Center for Young Onset Colorectal Cancer, David Liska, MD, joins the Cancer Advances Podcast to discuss Cleveland Clinic's integrated pr...
•
25:09

Evolving Care for Relapsed Multiple Myeloma
Beth Faiman, PhD, CNP, a Nurse Practitioner and Clinical Researcher at Cleveland Clinic specializing in multiple myeloma, joins the Cancer Advances podcast to discuss updates in managing relapsed and refractory multiple myeloma. Listen as Dr. F...
•
23:55

Leveraging Oncology Treatments for Vascular Anomalies
Michael Kelly, MD, PhD, a pediatric hematologist and oncologist at Cleveland Clinic Children's, joins the Cancer Advances podcast to discuss innovative care for vascular anomalies. In this episode, Dr. Kelly explains how they are exploring adva...
•
16:26

Unveiling the Cellular and Immunotherapy Service (CITS)
Inpatient Director of the Cellular and Immunotherapy Service, John Molina, MD, EdM, joins the Cancer Advances podcast to talk about the launching of the Cellular and Immunotherapy Service to manage the growing number of patients receiving cellu...
•
24:01

New Genomic Models for Leiomyosarcoma Treatment
Josephine K. Dermawan, MD, PhD, a soft tissue pathologist at Cleveland Clinic joins the Cancer Advances podcast to discuss the development of novel genomic risk stratification models for soft tissue and uterine leiomyosarcomas. Given the comple...
•
19:03

Exploring the Complexities of Neuroendocrine Tumors and Carcinoid Heart Disease
Chair of the Department of Gastroenterology, Hepatology and Nutrition, Michelle Kang Kim, MD, PhD, joins the Cancer Advances podcast to discuss neuroendocrine tumors and carcinoid heart disease. Listen as Dr. Kim shares her expertise on this ra...
•
18:03

Breaking Down Endocrine Therapy: Tailoring Breast Cancer Treatment for Young Women
Breast Medical Oncologist, Erin Roesch, MD, joins the Cancer Advances podcast to discuss endocrine therapy for breast cancer in young patients. Listen as Dr. Roesch explains the key differences in treatment for premenopausal women, including th...
•
23:06

Beyond the Sun: Uncovering the Genetic Risks of Melanoma
Joshua Arbesman, MD, Dermatologist and Director of the Pigmented Lesion Clinic at Cleveland Clinic, joins the Cancer Advances podcast to talk about the genetic risks of melanoma. Listen as Dr. Arbesman delves into the inherited predispositions ...
•
20:03
